Most Read Articles
one month ago
Quality-of-life (QoL) improvements in patients with psoriasis are faster and greater with secukinumab than etanercept treatment, according to a recent study.
4 months ago
Patients with hidradenitis suppurativa (HS) have four to eight times higher prevalence (3.3 percent) of inflammatory bowel disease (IBD; Crohn’s disease or ulcerative colitis) than the general northern European population (0.41 to 0.74 percent), results of a multicentre, cross-sectional study have found.
Tristan Manalac, one month ago
The fractional radiofrequency technique (fRF) reduces post-inflammatory hyperpigmentation (PIH) in treating atrophic acne scars in Asians compared with fractional laser methods, reports a review manuscript accepted for publishing in the Journal of Cosmetic and Laser Therapy.
Stephen Padilla, 12 days ago
The use of topical ruxolitinib 1.5% cream, a Janus kinase (JAK) inhibitor, delivers significant repigmentation in facial vitiligo, promising a new treatment for the said skin disease, reports a recent study.

New Updates in Topical Treatment of Psoriasis

6 months ago
During the 41st Annual Dermatology Conference held in Kuching, Sarawak, Professor Steven R. Feldman updated the participants on the latest in topical treatment of psoriasis. Highlights from the presentation are summarized below.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
one month ago
Quality-of-life (QoL) improvements in patients with psoriasis are faster and greater with secukinumab than etanercept treatment, according to a recent study.
4 months ago
Patients with hidradenitis suppurativa (HS) have four to eight times higher prevalence (3.3 percent) of inflammatory bowel disease (IBD; Crohn’s disease or ulcerative colitis) than the general northern European population (0.41 to 0.74 percent), results of a multicentre, cross-sectional study have found.
Tristan Manalac, one month ago
The fractional radiofrequency technique (fRF) reduces post-inflammatory hyperpigmentation (PIH) in treating atrophic acne scars in Asians compared with fractional laser methods, reports a review manuscript accepted for publishing in the Journal of Cosmetic and Laser Therapy.
Stephen Padilla, 12 days ago
The use of topical ruxolitinib 1.5% cream, a Janus kinase (JAK) inhibitor, delivers significant repigmentation in facial vitiligo, promising a new treatment for the said skin disease, reports a recent study.